181 related articles for article (PubMed ID: 30616142)
1. Fibroblast-derived integration-free iPSC line ISRM-NBS1 from an 18-year-old Nijmegen Breakage Syndrome patient carrying the homozygous NBN c.657_661del5 mutation.
Martins S; Bohndorf M; Graffmann N; Wruck W; Chrzanowska KH; Adjaye J
Stem Cell Res; 2019 Jan; 34():101372. PubMed ID: 30616142
[TBL] [Abstract][Full Text] [Related]
2. Lymphoblast-derived integration-free ISRM-CON9 iPS cell line from a 75year old female.
Martins S; Bohndorf M; Schröter F; Assar F; Wruck W; Sleegers K; Van Broeckhoven C; Adjaye J
Stem Cell Res; 2018 Jan; 26():76-79. PubMed ID: 29268155
[TBL] [Abstract][Full Text] [Related]
3. Generation of two Alpha-I antitrypsin deficiency patient-derived induced pluripotent stem cell lines ISRM-AATD-iPSC-1 (HHUUKDi011-A) and ISRM-AATD-iPSC-2 (HHUUKDi012-A).
Ncube A; Bewersdorf L; Spitzhorn LS; Loerch C; Bohndorf M; Graffmann N; May L; Amzou S; Fromme M; Wruck W; Strnad P; Adjaye J
Stem Cell Res; 2023 Sep; 71():103171. PubMed ID: 37506509
[TBL] [Abstract][Full Text] [Related]
4. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
[TBL] [Abstract][Full Text] [Related]
5. Generation of a Crigler-Najjar Syndrome Type I patient-derived induced pluripotent stem cell line CNS705 (HHUUKDi005-A).
Graffmann N; Martins S; Ljubikj T; Matte JC; Bohndorf M; Wruck W; Adjaye J
Stem Cell Res; 2021 Mar; 51():102167. PubMed ID: 33485181
[TBL] [Abstract][Full Text] [Related]
6. Lymphoblast-derived integration-free iPSC line AD-TREM2-1 from a 67year-old Alzheimer's disease patient expressing the TREM2 p.R47H variant.
Martins S; Yigit H; Bohndorf M; Graffmann N; Fiszl AR; Wruck W; Sleegers K; Van Broeckhoven C; Adjaye J
Stem Cell Res; 2018 May; 29():60-63. PubMed ID: 29602048
[TBL] [Abstract][Full Text] [Related]
7. Lymphoblast-derived integration-free iPSC line AD-TREM2-3 from a 74 year-old Alzheimer's disease patient expressing the TREM2 p.R47H variant.
Martins S; Yigit H; Bohndorf M; Graffmann N; Fiszl AR; Wruck W; Sleegers K; Van Broeckhoven C; Adjaye J
Stem Cell Res; 2018 Jul; 30():141-144. PubMed ID: 29902745
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal Instability and Molecular Defects in Induced Pluripotent Stem Cells from Nijmegen Breakage Syndrome Patients.
Halevy T; Akov S; Bohndorf M; Mlody B; Adjaye J; Benvenisty N; Goldberg M
Cell Rep; 2016 Aug; 16(9):2499-511. PubMed ID: 27545893
[TBL] [Abstract][Full Text] [Related]
9. Nijmegen Breakage Syndrome fibroblasts and iPSCs: cellular models for uncovering disease-associated signaling pathways and establishing a screening platform for anti-oxidants.
Mlody B; Wruck W; Martins S; Sperling K; Adjaye J
Sci Rep; 2017 Aug; 7(1):7516. PubMed ID: 28790359
[TBL] [Abstract][Full Text] [Related]
10. Generation of iPSC lines from a Nijmegen Breakage Syndrome patient.
Mlody B; Adjaye J
Stem Cell Res; 2015 Nov; 15(3):629-32. PubMed ID: 26987925
[TBL] [Abstract][Full Text] [Related]
11. Telomere attrition and dysfunction: a potential trigger of the progeroid phenotype in nijmegen breakage syndrome.
Habib R; Kim R; Neitzel H; Demuth I; Chrzanowska K; Seemanova E; Faber R; Digweed M; Voss R; Jäger K; Sperling K; Walter M
Aging (Albany NY); 2020 Jun; 12(12):12342-12375. PubMed ID: 32564008
[TBL] [Abstract][Full Text] [Related]
12. Lymphoblast-derived integration-free iPS cell line from a female 67-year-old Alzheimer's disease patient with TREM2 (R47H) missense mutation.
Schröter F; Sleegers K; Cuyvers E; Bohndorf M; Wruck W; Van Broeckhoven C; Adjaye J
Stem Cell Res; 2016 Nov; 17(3):553-555. PubMed ID: 27789408
[TBL] [Abstract][Full Text] [Related]
13. Lymphoblast-derived integration-free iPS cell line from a 69-year-old male.
Schröter F; Sleegers K; Bohndorf M; Wruck W; Van Broeckhoven C; Adjaye J
Stem Cell Res; 2016 Jan; 16(1):29-31. PubMed ID: 27345781
[TBL] [Abstract][Full Text] [Related]
14. Identification of the interactors of human nibrin (NBN) and of its 26 kDa and 70 kDa fragments arising from the NBN 657del5 founder mutation.
Cilli D; Mirasole C; Pennisi R; Pallotta V; D'Alessandro A; Antoccia A; Zolla L; Ascenzi P; di Masi A
PLoS One; 2014; 9(12):e114651. PubMed ID: 25485873
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of the NBN gene mutation c.657-661del5 in Southeast Germany.
Maurer MH; Hoffmann K; Sperling K; Varon R
J Appl Genet; 2010; 51(2):211-4. PubMed ID: 20453309
[TBL] [Abstract][Full Text] [Related]
16. Nijmegen breakage syndrome protein (NBN) causes resistance to methylating anticancer drugs such as temozolomide.
Eich M; Roos WP; Dianov GL; Digweed M; Kaina B
Mol Pharmacol; 2010 Nov; 78(5):943-51. PubMed ID: 20729302
[TBL] [Abstract][Full Text] [Related]
17. Generation of induced pluripotent stem cell (iPSC) line from a 36-year-old Charcot-Marie-Tooth disease patient with GJB1 mutation (CMTX).
Son D; Kang PJ; Yun W; You S
Stem Cell Res; 2017 May; 21():9-12. PubMed ID: 28677541
[TBL] [Abstract][Full Text] [Related]
18. NBS1 interacts with HP1 to ensure genome integrity.
Bosso G; Cipressa F; Moroni ML; Pennisi R; Albanesi J; Brandi V; Cugusi S; Renda F; Ciapponi L; Polticelli F; Antoccia A; di Masi A; Cenci G
Cell Death Dis; 2019 Dec; 10(12):951. PubMed ID: 31836699
[TBL] [Abstract][Full Text] [Related]
19. Heterozygous germ-line mutations in the NBN gene predispose to medulloblastoma in pediatric patients.
Ciara E; Piekutowska-Abramczuk D; Popowska E; Grajkowska W; Barszcz S; Perek D; Dembowska-Bagińska B; Perek-Polnik M; Kowalewska E; Czajńska A; Syczewska M; Czornak K; Krajewska-Walasek M; Roszkowski M; Chrzanowska KH
Acta Neuropathol; 2010 Mar; 119(3):325-34. PubMed ID: 19908051
[TBL] [Abstract][Full Text] [Related]
20. 657del5 mutation of the Nijmegen breakage syndrome gene (NBS1) in the Turkish population.
Tekin M; Akcayoz D; Ucar C; Gulen H; Akar N
Hum Biol; 2005 Jun; 77(3):393-7. PubMed ID: 16392640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
